Distal Femur Fx: ORIF(Open Reduction and Internal Fixation) vs DFR (Distal Femur Replacement Total Knee Arthroplasty)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-100
SponsorUniversity of Florida

About this trial

Supracondylar femur periprosthetic fractures about a total knee arthroplasty (TKA) are a catastrophic and challenging complication of TKA and unfortunately are increasing in incidence. Fixation of these fractures can be challenging due to altered anatomy for the TKA and the presence of the metallic femoral component and have a relatively high complication rate. As a result, some surgeons elect to treat these fractures with a distal femur replacement total knee arthroplasty (DFR). The purpose of this study is to prospectively evaluate periprosthetic femur fractures treated with ORIF or DFR and compare various outcomes measures (Get up and go times, KOOS Jr score)

Eligibility criteria

Qualifiers

English speaking patients

55 years or older with Su Type II or Su Type III periprosthetic femur fractures or OTA/OA 33C or 338/3 native knee distal femur fracturing requiring surgical intervention and are medically fit to undergo surgical intervention

Disqualifiers

Patients with an active total knee prosthetic infection

Patients unable to undergo surgical intervention

Patient with an open fracture

Non-English-speaking patients

Trial design

Treatments tested in this trial

  • Timed Up and Go Test on subjects with ORIF of distal femur fractures
  • Koos Jr assesment on subjects with ORIF of distal femur fractures
  • Timed Up and Go Test on subjects with DFR of distal femur fracture
  • Koos Jr assesment on subjects with DFR of distal femur fracture

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators